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Abstract
Children with human immunodeficiency virus (HIV) infection 
are more likely to have hearing loss and are more susceptible 
to middle ear infections. The purpose of this study was to 
quantitatively measure middle ear function, using tympanometry, 
in perinatally HIV-infected (PHIV) and HIV-uninfected 
children living in Cape Town, South Africa.Hearing-related 
health questionnaire data were obtained before testing. Bilateral 
otoscopy and tympanometry were completed in 37 PHIV and 24 
HIV-uninfected children. Otoscopy was performed to evaluate 
debris in ear canals and to observe the tympanic membrane. Ear 
canal volume (Vec), peak acoustic admittance (peak Ytm), and 
tympanogram peak pressure (TPP) were obtained. Presence of 
outer and middle ear pathologies was determined. Data were 
compared between PHIV and HIV-uninfected children. Parent/
caregiver report of past middle ear infection was higher in PHIV 
children (34.2%) compared with HIV-uninfected children 
(25.0%). Risk for reported history of middle ear infection was 
higher in PHIV children classified as World Health Organization 
(WHO) stage IV compared to other WHO stages. Outer ear 
otorrhea was present in two PHIV children and no HIV-
uninfected children. There were no significant differences for 
Vec, Ytm, and TPP between PHIV and HIV-uninfected children.
Tympanometry data for PHIV and HIV-uninfected children 
were similar, although PHIV children had a higher rate of outer 
ear otorrhea.
Keywords: Children,Perinatal HIV infection, Middle ear func-
tion, Otorrhea.
Introduction
Otitis media is a common pathology in children. The World 
Health Organization (WHO) reports the prevalence of 
chronic suppurative otitis media (CSOM) ranging from <1% 
to 7.8% [1]. Human immunodeficiency virus-infected (HIV-
infected) children who are immunocompromised are at higher 
risk for this opportunistic infection [2-8]. Further, greater 
immunosuppression in HIV-infected children is associated with 
both a higher rate of otitis media and greater severity of otitis 
media [6] and more symptomatic HIV-infected children are at 
higher risk for recurrent episodes of otitis media [2,5].
Additionally, recent research has shown that HIV-infected 
children <6 years receiving highly active antiretroviral therapy 
(HAART) had significantly lower prevalence of CSOM compared 
to those HIV-infected children ≤6 years not receiving HAART. 
Importantly, for HIV-infected children >6 years, there was no 
significant difference in the prevalence of CSOM between those 
receiving HAART and those not receiving HAART [8]. In most 
cases, CSOM is accompanied by otorrhea. In the Children with 
HIV Early Antiretroviral Therapy (CHER) trial, HIV-infected 
children who began ART early had a significantly lower risk of 
otorrhea compared to those on deferred ART [9]. To summarize, 
HIV-infected children are more at risk for various types of 
otitis media, with or without otorrhea, but HAART can reduce 
episodes of otitis media [8] along with decreased otorrhea in 
children on ART [9].
The prevalence and severity of otitis media in HIV-infected 
children has been studied; however, the evaluation of middle ear 
function using tympanometry is lacking. Thus, the purpose of 
this research was to evaluate middle ear function in perinatally 
HIV-infected (PHIV) and HIV-uninfected children.
Method
Participants
Children were recruited from pediatric outpatient clinics within 
Tygerberg Children’s Hospital, Cape Town, South Africa. All 
children were between the ages of 4 and 14 years at the time of 
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testing. This age range was appropriate given the typical age of 
children seen at pediatric clinics and given what was required of 
the child as a participant.
Procedures
San Diego State University Institutional Review Board (IRB) and 
the Stellenbosch University Health Research Ethics Committee 
approved all study procedures. Written informed consent to 
participate in the study was obtained from the child’s parent or 
legal guardian in the home language. Children >7 years of age 
provided assent.
Research assistants interviewed parent/caregivers in their home 
language and completed a hearing-related health questionnaire 
with them. Hearing-related questions included past reports of 
middle ear infections and parent/caregiver concerns about the 
child’s hearing. For PHIV children, data on HIV viral load, 
CD4%, CD4 cell count data, and disease severity were obtained 
from medical records within 6 months of middle ear measures.
Audiology graduate students completed the research protocol 
in a clinic room designated for this study. Outer ear canals and 
tympanic membranes were examined using otoscopy, and middle 
ear function was evaluated bilaterally using tympanometry (GSI 
39 Auto Tymp). Ear canal volume (Vec), peak acoustic admittance 
(peak Ytm) and tympanic peak pressure (TPP) were determined 
for each participant.
Statistical Analysis
Middle ear function was defined using Vec, peak Ytm, and TPP 
and was compared between PHIV and HIV-uninfected children. 
Risk factors for middle ear problems were evaluated by fitting 
logistic regression models to determine odds ratios (ORs) and 
corresponding 95% confidence intervals (CIs). For PHIV children 
only, associations between measures of middle ear function and 
HIV disease severity as well as HIV treatment were evaluated. 
Middle ear data were analyzed individually for each ear using the 
Wilcoxon rank-sum test. Analysis of percent of parent/caregiver 
report of middle ear infection was conducted using Fisher’s exact 
test. All statistical analyses were conducted using SAS Version 
9.1.2 (SAS Institute, Cary, NC).
Results
This study included the same 61 children (37 PHIV [23 
females, 14 males], 24 HIV-uninfected [8 females, 16 males]) 
that participated in the study by Torre et al. [10]. Extensive 
demographic data are shown in Torre et al. [10]. Briefly, in Table 
1 PHIV children were mostly female (62.2%), black race (73.0%) 
and spoke Xhosa (67.6%) as the primary language at home. In 
contrast, HIV-uninfected children were mostly male (66.7%), 
mixed race (58.3%) and spoke Afrikaans (58.3%) as the primary 
language at home. Lastly, 34.2% of parents/caregivers reported a 
middle ear infection in a PHIV child, and 25% reported a middle 
ear infection in an HIV-uninfected child. Though this difference 
was not statistically significant, the unadjusted risk for reported 
middle ear infection was higher in PHIV children (OR=1.70, 95% 
CI: 0.54-5.34, p=0.37). Furthermore, PHIV children classified 
as WHO stage IV had twice the odds of reported middle ear 
infections compared to children with WHO stage II or III 
classification (OR=2.18, 95% CI: 0.53-9.01, p=0.28); however, 
this risk was not statistically significant. Since all PHIV children 
had HIV viral loads below the lower detectable limit (<400 or <50 
copies/mL), therefore, this variable was not used in any analyses. 
Mean CD4% was 35.5 (SD=6.9) and mean CD4 cell count was 
1301.7 cells/mm3 (SD=592.3). Four children had missing CD4% 
data and two children had missing CD4 cell count data. CD4% 
and CD4 cell count were not significant predictors of reported 
middle ear infections [CD4%: F(1,30)=1.18, p>0.05; CD4 cell 
count: F(1,30)=3.02, p>0.05].
Two of the PHIV children were identified with otorrhea and im-
mediately referred to their physician once testing was completed. 
No HIV-uninfected children presented with otorrhea.
For children with flat tympanograms, peak Ytm was 0 millimhos, 
and this value was included in subsequent analyses. However, 
TPP cannot be determined for flat tympanograms, so this value 
was missing. Thus, six PHIV children had flat tympanograms 
with missing TPP data and two of these children had flat 
tympanograms bilaterally. Two HIV-uninfected children had 
a flat tympanogram and one of these HIV-uninfected children 
had flat tympanograms bilaterally. All children with flat 
tympanograms were referred to their physician for follow-up 
testing. Table 2 shows the means and standard deviations for the 
tympanogram data in each ear by HIV infection status. Although 
PHIV children had lower mean peak Ytm and more negative 
TPP, none of the differences between groups were statistically 
significant. In subsequent analyses of PHIV children only, WHO 
status, CD4%, and CD4 cell count also were not associated with 
poorer middle ear function.
Discussion
PHIV children in the present study had a higher rate of 
reported middle ear infections, more otorrhea, and more flat 
tympanograms compared with HIV-uninfected children. This is 
one of the few studies to incorporate quantitative tympanometry 
data to evaluate middle ear function in PHIV children. Although 
other researchers [3,11] have reported types of tympanograms for 
children, specific data were not reported. For example, Chao et 
al. [3] used tympanometry to evaluate middle ear pathologies in 
HIV-infected children, using a classification of: Type A (normal), 
Type B (flat), or Type C (negative middle ear pressure) and found 
38.1% with flat tympanograms either unilaterally or bilaterally. 
This rate is higher than the rate in the current study which 
presented only 8 children (13.1%) with flat tympanograms. This 
difference is most likely a result of the health of the HIV-infected 
children in Chao et al. [3]. In that study, 40 (29.8%) HIV-infected 
children had a most recent CD4 count ≤500 cells/mm3 and 59 
(44.4%) HIV-infected children had a most recent HIV viral load 
>400 copies/mL.
Two PHIV children in the current study had present otorrhea 
whereas no HIV-uninfected child presented with otorrhea. 
Statistics were not completed given the small numbers, though 
other researchers have shown that HIV-infected children in Africa 
have significantly more present or past episodes of otorrhea [7] 
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and significantly more episodes of recurrent otorrhea [12].
None of the differences in the current study were statistically 
significant. These findings were most likely a result of PHIV 
children who started HAART at a relatively early age and who 
were virologically suppressed and immunologically competent 
based on mean CD4% and mean CD4 cell count. Adherence 
to HAART maintains virological suppression but these initial 
data suggest that HAART may not be ototoxic to the middle ear. 
Because the mean age of the children in Chao et al. [3] was just 
under 10 years, these children were on HAART for just over 4 
years. As a result, they started treatment later than the present 
study cohort. The PHIV children in the current study were all 
on HAART, had high CD4 cell counts, and undetectable viral 
loads.
It should be noted that most of the PHIV children in the present 
study were taking a specific HAART regimen (zidovudine, 
lamivudine, and lopinavir/ritonavir) and were virologically 
controlled. This is important because younger children taking 
HAART had significantly lower rate of chronic otitis media 
compared to those children on ART [8]. The HIV-infected 
children on HAART did, however, have significantly higher CD4 
cell counts compared with HIV-infected children on ART. The 
PHIV children in the current study were all on varying HAART 
regimens, had high CD4 cell counts, and undetectable viral loads. 
Thus, no comparisons can be made using these variables.
PHIV children in this study with a WHO stage IV classification 
did have a higher, but not significant, risk of reported middle 
ear infections. Further, WHO status was not associated with any 
tympanometry variables. The lack of significance differences is 
most likely a result of small sample size. To date, this is the first 
study to evaluate the association between HIV disease variables 
and middle ear characteristics. The association between HIV 
disease status and hearing loss has been reported. HIV-infected 
children identified as a current or prior CDC class C diagnosis 
had significantly higher odds of hearing loss compared to those 
children with any other CDC classification [11].
Early identification of middle ear problems is important for all 
children, but especially for those who may have compromised 
Table 1: Sex distribution and responses to specific hearing health questions stratified by infection status are shown for the 37 PHIV children and 




Female 23 (62.2%) 8 (33.3%)
Mean age, yrs (SD) 6.7 (1.6) 6.5 (1.6)
Male 14 (37.8%) 16 (66.7%)
Mean age, yrs (SD) 6.9 (1.6) 8.0 (1.4)
Mother/caregiver report of middle ear infection1 (n, % Yes) 13 (34.2%) 6 (25.0%)
Mother/caregiver suspect a hearing loss (n, % Yes) 10 (27.0%) 1 (4.1%)
Has child ever had a hearing test (n, % Yes) 14 (37.8%) 7 (29.2%)
Has child ever used hearing aids (n, % Yes) 1 (2.7%) 0 (0.0%)
1Two mother/caregivers of a PHIV child did not report history of middle ear infection
Table 2: Means and standard deviations for ear canal volume, peak Ytm, and tympanogram peak pressure are shown. These data are further 
stratified by ear and HIV infection status
Infection Status
Audiometric Outcome PHIV HIV-uninfected p-value1
Ear Canal Volume (Vec), in mmhos
Left Vec Mean (SD) 0.7 (0.2) 0.8 (0.2) 0.28
Right Vec Mean (SD) 0.7 (0.2) 0.8 (0.2) 0.08
Peak Ytm, in mmhos
Left Ytm Mean (SD) 0.5 (0.3) 0.7 (0.8) 0.57
Right Ytm Mean (SD) 0.5 (0.3) 0.7 (0.6) 0.17
Tympanogram Peak Pressure (TPP), in daPa
Left TPP Mean (SD) -44.8 (67.3) -24.5 (30.1) 0.11
Right TPP Mean (SD) -47.4 (45.7) -31.7 (51.6) 0.22
1Comparison between PHIV and HIV-uninfected children. 
mmhos-millimhos; SD-standard deviation; daPa-dekapascals
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immune systems, such as HIV-infected children. Recurrent otitis 
media in younger children has been associated with phonological 
development delays [13] and, given that more symptomatic HIV-
infected children are more likely to have recurrent episodes of 
otitis media [2,5], early identification and treatment is therefore 
necessary. Treatment of acute otitis media episodes is most often 
with antibiotics in an effort to eliminate the infection. When 
various antibiotic regimens are unsuccessful, chronic otitis 
media can also be treated with tympanostomy tubes. The risk 
here is that the use of tubes has been shown to lead to higher 
pure-tone thresholds [14]. The benefits of treatment should 
therefore be weighed against the side effects, since permanent 
hearing loss such as this can impact a child’s speech and language 
development [15-17].
One limitation of this study is that the lack of statistical 
significance could have been a result of the small sample size. 
Another limitation is that only PHIV and HIV-uninfected 
children were included in the present study. Further testing of 
middle ear function is needed in children who are HIV-exposed, 
but uninfected (HEU). With the mother-to-child-transmission 
rates decreasing [18,19] due to better perinatal care for HIV-
infected mothers, there will be increasing numbers of HEU 
children seen at clinics. Determining the effects of HIV and ART 
exposure on middle ear function will further contribute to the 
literature on perinatal HIV and overall auditory function.
Conclusion
In conclusion, by including quantitative tympanometry data, 
the results of this study contribute to a growing literature on the 
effects of HIV on middle ear function in children. PHIV children 
in this study had a higher risk of middle ear problems; none of the 
risks, however, were statistically significant. The lack of statistical 
significance does not preclude the need for PHIV children to 
be followed carefully for middle ear pathologies. Finally, this 
study can be seen to have significant clinical implications in the 
assessment and management of these groups. First, otoscopy and, 
at a minimum, screening tympanometry should be implemented 
during routine check-ups to identify middle ear problems, 
specifically flat tympanograms, in PHIV children. Second, 
starting children on early ART will result in the preservation of 
healthy CD4 levels, and virological control can ultimately reduce 
middle ear problems in PHIV children.
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